BOSTON, Sept 1 (Reuters) - Billionaire investor William Ackman's portfolios climbed nearly 6 percent in August, boosted by strong gains at drug company Valeant Pharmaceuticals International Inc where changes that the hedge fund manager has helped push for appear to be instilling new